{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:17:46Z","timestamp":1788412666911,"version":"build-2803163510"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec0123\">\n<jats:title>Background<\/jats:title>\n<jats:p>A new lymphoedema-specific Patient Reported Outcome Measure (LYMPROM<jats:sup>\u00a9<\/jats:sup>) was developed to help patients easily report the impact of their lymphoedema and enable lymphoedema therapists to understand what matters most to patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec0124\">\n<jats:title>Aims<\/jats:title>\n<jats:p>This paper describes the validation of LYMPROM<jats:sup>\u00a9<\/jats:sup> for adults with lymphoedema.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec0125\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A multi-phased iterative review was undertaken to investigate the reliability and validity of LYMPROM<jats:sup>\u00a9<\/jats:sup>. Face and content validity were reviewed by surveying patient representatives and healthcare professionals, along with the validity of LYMPROM<jats:sup>\u00a9<\/jats:sup> Cymraeg, a Welsh translation. Following COSMIN guidelines, validation study phases used anonymised routinely collected data to examine internal consistency, structural validity, construct validity (compared with the EQ5D-5L), measurement error, test-retest reliability and responsiveness.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec0126\">\n<jats:title>Results<\/jats:title>\n<jats:p>LYMPROM<jats:sup>\u00a9<\/jats:sup> demonstrated validity (content and construct) and reliability (test-retest, internal consistency). All items were regarded as relevant, comprehensive and clear, with item content validity index (CVI) between 0.83 to 1.00, and average overall assessment of 0.94. Robust development of LYMPROM<jats:sup>\u00a9<\/jats:sup> Cymraeg ensured appropriate translation into Welsh.<\/jats:p>\n<jats:p>LYMPROM<jats:sup>\u00a9<\/jats:sup> item scores, with means and medians generally in the lower half of the scale, were positively correlated, as were three (Physical health, Social health and Emotional health) domain scores (domain correlations: 0.595 to 0.812). LYMPROM<jats:sup>\u00a9<\/jats:sup> total and domain scores showed moderate negative correlations (-0.577 to -0.435) with EQ5D-5L measures.<\/jats:p>\n<jats:p>LYMPROM<jats:sup>\u00a9<\/jats:sup> total and domain scores showed good test-retest (within two weeks) properties, with little or no change in mean or median scores, and strong positive correlations between test and retest scores (Total: 0.919; Physical health domain: 0.922; Social health domain: 0.889; Emotional health domain: 0.820).<\/jats:p>\n<jats:p>LYMPROM<jats:sup>\u00a9<\/jats:sup> showed good responsiveness, with strong, positive correlations between total and domain initial and repeat (between four weeks and seven months later) scores, with a slight reduction in scores (-3.8 to -2.0 units) and some indication of relationships between reduction and time interval (Total: p\u2009=\u20090.025; Physical health domain: 0.034; Social health domain: 0.181; Emotional health domain: 0.009).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec0127\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Evidence shows that LYMPROM<jats:sup>\u00a9<\/jats:sup> offers a reliable and valid tool for use in clinical practice. Scores on three domains allow a more granular assessment of the patient\u2019s view of their condition; these scores and the total LYMPROM<jats:sup>\u00a9<\/jats:sup> score exhibit moderate correlations with more generic EQ5D-5L measures. Further research will explore relationships between patient-level characteristics and LYMPROM<jats:sup>\u00a9<\/jats:sup> responses, and extend initial work on its cross-cultural validity.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0315314","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T17:54:27Z","timestamp":1748022867000},"page":"e0315314","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["A new validated Lymphoedema-specific Patient Reported Outcome Measure (LYMPROM) for adults with Lymphoedema"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6631-9629","authenticated-orcid":true,"given":"Melanie","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Gabe-Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7993-0179","authenticated-orcid":true,"given":"Ioan","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"pone.0315314.ref001","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s41687-018-0061-6","article-title":"How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis","volume":"2","author":"J Greenhalgh","year":"2018","journal-title":"J Patient Rep Outcomes"},{"issue":"3","key":"pone.0315314.ref002","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/SLA.0000000000004253","article-title":"The surgeon\u2019s perceived value of patient-reported outcome measures (PROMs): an exploratory qualitative study of 5 different surgical subspecialties","volume":"275","author":"D Mou","year":"2022","journal-title":"Annals of Surgery"},{"issue":"2","key":"pone.0315314.ref003","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMp0904131","article-title":"A strategy for health care reform--toward a value-based system","volume":"361","author":"ME Porter","year":"2009","journal-title":"N Engl J Med"},{"key":"pone.0315314.ref004","first-page":"147","article-title":"Lymphoedema: an underestimated health problem","volume":"147","author":"C Moffatt","year":"2002","journal-title":"British Journal of Dermatology"},{"key":"pone.0315314.ref005","doi-asserted-by":"crossref","first-page":"101720","DOI":"10.1016\/j.ejon.2019.101720","article-title":"Exploring the impact of lymphoedema on individuals and if lymphatic venous anastomosis surgery effects perceptions on quality of life: a qualitative study","volume":"44","author":"M Thomas","year":"2020","journal-title":"European Journal of Oncology Nursing"},{"issue":"3","key":"pone.0315314.ref006","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/iwj.12648","article-title":"The impact of lower limb chronic oedema on patients\u2019 quality of life","volume":"14","author":"A Greene","year":"2017","journal-title":"Int Wound J"},{"issue":"2","key":"pone.0315314.ref007","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/lrb.2015.0027","article-title":"Symptom Frequency, Intensity, and Distress in Patients with Lower Limb Lymphedema","volume":"14","author":"DP Stolldorf","year":"2016","journal-title":"Lymphat Res Biol"},{"issue":"3","key":"pone.0315314.ref008","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/cncr.21195","article-title":"Psychologic and social sequelae of secondary lymphedema: a review","volume":"104","author":"J McWayne","year":"2005","journal-title":"Cancer"},{"key":"pone.0315314.ref009","unstructured":"Framework L. Best practice for the management of lymphoedema. International Consensus. London: MEP Ltd. 2006:3-52. [cited 2021 Nov 15] Available from: https:\/\/www.lympho.org\/portfolio\/best-practice-for-the-management-of-lymphoedema\/"},{"issue":"11","key":"pone.0315314.ref010","doi-asserted-by":"crossref","first-page":"623","DOI":"10.12968\/bjon.2013.22.11.623","article-title":"Chronic oedema: impact and management","volume":"22","author":"M Todd","year":"2013","journal-title":"British Journal of Nursing"},{"issue":"4","key":"pone.0315314.ref011","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/NNR.0b013e31824f82b2","article-title":"Self-management of lymphedema: a systematic review of the literature from 2004 to 2011","volume":"61","author":"SH Ridner","year":"2012","journal-title":"Nurs Res"},{"issue":"1","key":"pone.0315314.ref012","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1742-4801.2005.00066.x","article-title":"Health-related quality of life with lymphoedema: a review of the literature","volume":"2","author":"PA Morgan","year":"2005","journal-title":"Int Wound J"},{"issue":"2","key":"pone.0315314.ref013","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1049732306297660","article-title":"Experiences of living with non-cancer-related lymphedema: implications for clinical practice","volume":"17","author":"LK Bogan","year":"2007","journal-title":"Qual Health Res"},{"key":"pone.0315314.ref014","unstructured":"Lymphoedema Wales Clinical Network [LWCN], 2023. Annual Report."},{"issue":"10","key":"pone.0315314.ref015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.12968\/bjon.2021.30.10.592","article-title":"Development of the lymphoedema patient reported outcome measure (LYMPROM)","volume":"30","author":"M Gabe-Walters","year":"2021","journal-title":"British Journal of Nursing"},{"issue":"3","key":"pone.0315314.ref016","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1245\/s10434-020-09346-0","article-title":"Patient-Reported Outcome Measures in Lymphedema: A Systematic Review and COSMIN Analysis","volume":"28","author":"LM Beelen","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"pone.0315314.ref017","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1245\/s10434-021-09920-0","article-title":"Discussion: \u201cDevelopment and Psychometric Validation of a Patient-Reported Outcome Measure for Arm Lymphedema: LYMPH-Q Upper Extremity Module\u201d","volume":"28","author":"MV Schaverien","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"pone.0315314.ref018","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1245\/s10434-020-09348-y","article-title":"Patient-Reported Outcome Measures in Lymphedema: A Systematic Review and COSMIN Analysis","volume":"28","author":"MV Schaverien","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"pone.0315314.ref019","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1524-4733.2008.00470.x","article-title":"Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report","volume":"12","author":"SJ Coons","year":"2009","journal-title":"Value Health"},{"issue":"11","key":"pone.0315314.ref020","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1007\/s11136-020-02711-2","article-title":"First steps in PROMs and PREMs collection in Wales as part of the prudent and value-based healthcare agenda","volume":"30","author":"K Withers","year":"2021","journal-title":"Qual Life Res"},{"issue":"4","key":"pone.0315314.ref021","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","article-title":"The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study","volume":"19","author":"LB Mokkink","year":"2010","journal-title":"Qual Life Res"},{"key":"pone.0315314.ref022","unstructured":"Mokkink LB, Prinsen CA, Patrick DL, Alonso J, Bouter LM, De Vet HC, Terwee CB. COSMIN Study Design checklist for Patient-reported outcome measurement instruments. Amsterdam, The Netherlands. 2019 Jul;2019:1-32."},{"issue":"2","key":"pone.0315314.ref023","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","article-title":"Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR task force for translation and cultural adaptation","volume":"8","author":"D Wild","year":"2005","journal-title":"Value Health"},{"key":"pone.0315314.ref024"},{"issue":"5","key":"pone.0315314.ref025","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/nur.20147","article-title":"The content validity index: are you sure you know what\u2019s being reported? Critique and recommendations","volume":"29","author":"DF Polit","year":"2006","journal-title":"Res Nurs Health"},{"issue":"4","key":"pone.0315314.ref026","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/nur.20199","article-title":"Is the CVI an acceptable indicator of content validity? Appraisal and recommendations","volume":"30","author":"DF Polit","year":"2007","journal-title":"Res Nurs Health"},{"issue":"2","key":"pone.0315314.ref027","doi-asserted-by":"crossref","first-page":"49","DOI":"10.21315\/eimj2019.11.2.6","article-title":"ABC of Content Validation and Content Validity Index Calculation","volume":"11","author":"MSB Yusoff","year":"2019","journal-title":"EIMJ"},{"issue":"4","key":"pone.0315314.ref028","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/014662168801200410","article-title":"Set Correlation and Contingency Tables","volume":"12","author":"J Cohen","year":"1988","journal-title":"Applied Psychological Measurement"},{"key":"pone.0315314.ref029","doi-asserted-by":"crossref","unstructured":"Nelson EC, Eftimovska E, Lind C, Hager A, Wasson JH, Lindblad S. Patient reported outcome measures in practice. British Medical Journal. 2015 Feb 10;350.","DOI":"10.1136\/bmj.g7818"},{"key":"pone.0315314.ref030","unstructured":"Thomas M, Humphreys I, Pike C, Morgan K, Noble-Jones R. Cost impact and outcomes of 50 lymphoedema cases using adjustable compression garments. Journal of Community Nursing. 2024 Jun 1;38(3)."},{"issue":"8","key":"pone.0315314.ref031","doi-asserted-by":"crossref","first-page":"360","DOI":"10.12968\/bjon.2024.33.8.360","article-title":"Lymphoedema specialists embedded into community nurse and wound services: impacts and outcomes","volume":"33","author":"M Thomas","year":"2024","journal-title":"Br J Nurs"},{"issue":"18","key":"pone.0315314.ref032","doi-asserted-by":"crossref","first-page":"866","DOI":"10.12968\/bjon.2023.32.18.866","article-title":"Challenges involved in collecting and analysing the reported experiences of patients with lymphoedema","volume":"32","author":"M Gabe-Walters","year":"2023","journal-title":"Br J Nurs"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0315314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T17:54:40Z","timestamp":1748022880000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0315314"}},"subtitle":[],"editor":[{"given":"Kathleen","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0315314","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}